We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMVT icon
401
Immunovant
IMVT
$7.92B
$60.1K ﹤0.01%
3,758
– –
HIW icon
402
Highwoods Properties
HIW
$3.83B
$59.6K ﹤0.01%
1,916
-92
-5% -$2.71K
NHI icon
403
National Health Investors
NHI
$3.84B
$57.6K ﹤0.01%
821
-39
-5% -$2.86K
TWST icon
404
Twist Bioscience
TWST
$5.31B
$55.9K ﹤0.01%
1,520
– –
APLS
405
DELISTED
Apellis Pharmaceuticals
APLS
$55.1K ﹤0.01%
3,185
– –
LGND icon
406
Ligand Pharmaceuticals
LGND
$5.88B
$55K ﹤0.01%
484
– –
CDP icon
407
COPT Defense Properties
CDP
$4.4B
$54.9K ﹤0.01%
1,991
-143
-7% -$3.87K
VCEL icon
408
Vericel Corp
VCEL
$2.35B
$53.8K ﹤0.01%
1,264
– –
VCYT icon
409
Veracyte
VCYT
$4.43B
$53.6K ﹤0.01%
1,984
– –
BNL icon
410
Broadstone Net Lease
BNL
$4.31B
$53.5K ﹤0.01%
3,335
-236
-7% -$3.78K
DNLI icon
411
Denali Therapeutics
DNLI
$3.77B
$51.6K ﹤0.01%
3,685
– –
INDV icon
412
Indivior Pharmaceuticals
INDV
$4.83B
$51.4K ﹤0.01%
3,490
– –
ARWR icon
413
Arrowhead Research
ARWR
$12.2B
$50.3K ﹤0.01%
3,186
– –
APGE icon
414
Apogee Therapeutics
APGE
$10.1B
$50.1K ﹤0.01%
1,153
– –
RXRX icon
415
Recursion Pharmaceuticals
RXRX
$1.58B
$49.5K ﹤0.01%
9,775
– –
NVCR icon
416
NovoCure
NVCR
$1.81B
$49.3K ﹤0.01%
2,770
– –
AGIO icon
417
Agios Pharmaceuticals
AGIO
$2.09B
$48.6K ﹤0.01%
1,460
– –
BCRX icon
418
BioCryst Pharmaceuticals
BCRX
$2.42B
$47.5K ﹤0.01%
5,303
– –
IBRX icon
419
ImmunityBio
IBRX
$7.2B
$47.1K ﹤0.01%
17,843
– –
FCPT icon
420
Four Corners Property Trust
FCPT
$2.88B
$47K ﹤0.01%
1,748
-84
-5% -$2.31K
ZLAB icon
421
Zai Lab
ZLAB
$2.06B
$46.7K ﹤0.01%
1,336
– –
APLE icon
422
Apple Hospitality REIT
APLE
$3.98B
$46.7K ﹤0.01%
4,002
-315
-7% -$3.69K
IDYA icon
423
IDEAYA Biosciences
IDYA
$3.43B
$46.5K ﹤0.01%
2,213
– –
HRMY icon
424
Harmony Biosciences
HRMY
$2.06B
$46.1K ﹤0.01%
1,460
– –
CGON icon
425
CG Oncology
CGON
$6.16B
$45K ﹤0.01%
1,731
– –
15 16
17
18 19

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.